WHAT IS APTACARE AND WHAT DO WE DO?

At Aptacare, we have developed a unique solution to nullify the requirement of Frozen Section Analysis

With Use Of APTAMER TECHNOLOGY We are able to achieve real time results.

​

Aptamer technology revolutionizes cancer detection by utilizing specific DNA or RNA molecules called aptamers. These molecules are meticulously selected through SELEX, a process involving iterative binding, isolation, and amplification. Aptamers exhibit remarkable specificity and affinity for target molecules found on cancer cells.

In cancer detection, aptamers are designed to bind exclusively to these target molecules, enabling the identification of cancer cells amidst healthy ones. Aptamers are often linked to detection molecules like fluorescent dyes or enzymes. When an aptamer binds to its target on a cancer cell, the attached molecule emits a detectable signal, aiding visualization.

In the context of your "Aptaclear" product, aptamers trigger a color change in a solution applied after tumor removal. This occurs due to the aptamer's specific interaction with cancer cells, causing a molecular shift that results in a visible color alteration. This transformation is detectable using UV light, facilitating quick and precise confirmation of cancerous cell presence.

Aptamer technology offers immense potential for personalized cancer detection by tailoring aptamers to target specific biomarkers associated with various cancer types. The precise binding ability of aptamers enhances accuracy, reduces waiting times for results, and empowers surgeons with immediate feedback during procedures. As a result, aptamer-based solutions like "Aptaclear" hold promise for advancing cancer diagnostics and improving patient outcomes.